Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medadex Pharmaceuticals appears to have been a small private healthcare/pharmaceutical venture based in Atlanta, Georgia. Publicly available evidence indicates it operated first as Medadex, focused on pharmaceutical, medical supply, biotech, and medical services outsourcing/sales support, and was later described in 2020 as "Medadex Pharma," a pharmaceutical division or subsidiary associated with Verde Leaf focused on cannabinoid product development and validation. The company does not appear to have had a clearly documented clinical-stage drug pipeline, and available information points more to commercial operations, business development, and cannabinoid/CBD product strategy than to traditional drug development. Corporate registry traces for related Georgia entities suggest the business is no longer active. Overall, Medadex Pharmaceuticals looks like a small, now-defunct private healthcare/pharma-related company rather than an established clinical biotech issuer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medadex Pharmaceuticals.